Table:
begin	end	state
1	11	non-cytoplasmic
12	35	transmembrane
36	41	cytoplasmic
42	71	transmembrane
72	76	non-cytoplasmic
77	97	transmembrane
98	108	cytoplasmic
109	133	transmembrane
134	139	non-cytoplasmic
140	140	transmembrane
141	142	non-cytoplasmic
143	162	transmembrane
163	168	cytoplasmic
169	190	transmembrane
191	201	non-cytoplasmic
202	223	transmembrane
224	261	cytoplasmic
262	283	transmembrane
284	324	non-cytoplasmic
325	346	transmembrane
347	357	cytoplasmic
358	381	transmembrane
382	392	non-cytoplasmic
393	410	transmembrane
411	416	cytoplasmic
417	447	transmembrane
448	467	non-cytoplasmic
468	488	transmembrane
489	505	cytoplasmic

Input:
>3609738
MLEGLLIGLQTAFSIQNLAMVIGGCLIGTFIGMLPGLGPMSIIAIMIPVAISLGDPSAAL
ILLAGVYYGAIFGGSTSSILLNAPGVAGTVATSFDGYPMAQQGKAGKALTIAAIASFAGG
TIGAILLMVFAPALSSVALLFHSAEYFALMVVGLSAIAAFAGTGQVAKALLMTILGLIMA
TVGEGALFASPRFTMGLMDLQSGFGFITLAMAMFALPEALFLVMNPLRAASGQGGGEIKD
LRITRAEARSIAPVIGRQSVQGFFIGVLPGAGATIASFLGYAVERNIASKDEQAEFGKGS
VKGLAAPETANNAACTGSFVPLLTLGIPGSGTTAILLGALLALNVSPGPRLMIDAPEIFW
AVIMSMFIGNLVLLILNLPLIPYIAKILSVPRNYLIPFILFFTLMGAYIGQNNATELLLL
VGFGICATILKFADYPLAPLLIGFILGGLLENNFSRAMQLYDGISFIWERPMTLGLLVIA
ALLIILPSYRNRRAKARAAGVADGD

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server